22nd Century’s Receives USDA Phytosanitary Certificate to Export Proprietary Tobacco Seeds
October 22 2015 - 7:50AM
Business Wire
Central American growing program may enable
the Company to bring reduced exposure tobacco products to
price-conscious smokers around the world.
22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco
harm reduction, announced today that the Company is exporting
multiple varieties of its proprietary tobacco seeds to Central
America for testing and possible expanded agricultural production.
The United States Department of Agriculture (USDA) issued a
phytosanitary certificate to 22nd Century to facilitate export of
the Company’s proprietary Nicotiana tabacum (tobacco) seeds to
growers in Central America.
22nd Century remains committed to utilizing US-grown tobacco for
cigarettes manufactured for sale in the United States and other
countries. However, in order to satisfy demand for its proprietary
tobacco in parts of the world unable to afford premium-priced leaf,
22nd Century is conducting field trials with select growers in
Central America.
The first crops grown from the Company’s proprietary tobacco
varieties in Central America will come due for harvest in early
2016. 22nd Century anticipates that the field trials will produce
tobacco that compares favorably with the Company’s previous
contract-grown crops. With growing seasons all year long, plentiful
rainfall, and tens of thousands of acres of suitable farmland,
Central American farms have the potential to produce large
quantities of quality tobacco leaf for 22nd Century – at extremely
attractive prices.
“Some of the world’s largest cigarette markets are highly price
sensitive,” explained Henry Sicignano, III, President and CEO of
22nd Century. “Our Central American growing program may enable 22nd
Century to provide price-conscious smokers in many parts of the
world with incredibly important products that no other company can
provide, including Very Low Nicotine tobacco cigarettes – with 95%
less nicotine than conventional cigarettes – as recently described
in The New England Journal of Medicine.”
About 22nd Century Group, Inc.
22nd Century Group is a plant biotechnology company focused on
technology that allows it to increase or decrease the level of
nicotine in tobacco plants and the level of cannabinoids in
cannabis plants through genetic engineering and plant breeding. The
Company’s primary mission is to reduce the harm caused by smoking.
22nd Century currently owns or exclusively controls more than 185
issued patents and more than 50 pending patent applications around
the world. The Company’s strong IP position led to a licensing
agreement with British American Tobacco (“BAT”), the world’s second
largest tobacco company. Visit www.xxiicentury.com for more
information.
Cautionary Note Regarding Forward-Looking Statements: This press
release contains forward-looking information, including all
statements that are not statements of historical fact regarding the
intent, belief or current expectations of 22nd Century Group, Inc.,
its directors or its officers with respect to the contents of this
press release. The words “may,” “would,” “will,” “expect,”
“estimate,” “anticipate,” “believe,” “intend” and similar
expressions and variations thereof are intended to identify
forward-looking statements. We cannot guarantee future results,
levels of activity or performance. You should not place undue
reliance on these forward-looking statements, which speak only as
of the date that they were made. These cautionary statements should
be considered with any written or oral forward-looking statements
that we may issue in the future. Except as required by applicable
law, including the securities laws of the United States, we do not
intend to update any of the forward-looking statements to conform
these statements to reflect actual results, later events or
circumstances, or to reflect the occurrence of unanticipated
events. You should carefully review and consider the various
disclosures made by us in our annual report on Form 10-K for the
year ended December 31, 2014, filed on February 6, 2015, including
the section entitled “Risk Factors,” and our other reports filed
with the U.S. Securities and Exchange Commission which attempt to
advise interested parties of the risks and factors that may affect
our business, financial condition, results of operation and cash
flows. If one or more of these risks or uncertainties materialize,
or if the underlying assumptions prove incorrect, our actual
results may vary materially from those expected or projected.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151022005500/en/
Investor Relations for 22nd Century Group, Inc.:Andrew
Haag, 866-976-4784xxii@irthcommunications.comorRedington, Inc.Tom
Redington, 203-222-7399
22nd Century (AMEX:XXII)
Historical Stock Chart
From Mar 2024 to Apr 2024
22nd Century (AMEX:XXII)
Historical Stock Chart
From Apr 2023 to Apr 2024